INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $429,000 | -21.1% | 145,866 | 0.0% | 0.01% | -41.7% |
Q1 2019 | $544,000 | +94.3% | 145,866 | +108.4% | 0.01% | +100.0% |
Q4 2018 | $280,000 | -28.0% | 70,000 | 0.0% | 0.01% | -14.3% |
Q3 2018 | $389,000 | +17.9% | 70,000 | 0.0% | 0.01% | +16.7% |
Q1 2018 | $330,000 | +14.2% | 70,000 | 0.0% | 0.01% | +20.0% |
Q4 2017 | $289,000 | -34.9% | 70,000 | 0.0% | 0.01% | -44.4% |
Q3 2017 | $444,000 | +182.8% | 70,000 | +250.0% | 0.01% | +200.0% |
Q2 2017 | $157,000 | -72.6% | 20,000 | -76.9% | 0.00% | -70.0% |
Q1 2017 | $574,000 | -4.3% | 86,719 | 0.0% | 0.01% | -9.1% |
Q4 2016 | $600,000 | -25.3% | 86,719 | 0.0% | 0.01% | +10.0% |
Q3 2016 | $803,000 | +0.2% | 86,719 | 0.0% | 0.01% | -9.1% |
Q2 2016 | $801,000 | -13.7% | 86,719 | -18.7% | 0.01% | -8.3% |
Q1 2016 | $928,000 | -69.8% | 106,719 | -76.6% | 0.01% | -33.3% |
Q4 2015 | $3,071,000 | +396.9% | 456,719 | +326.4% | 0.02% | +350.0% |
Q3 2015 | $618,000 | -81.6% | 107,103 | -73.9% | 0.00% | -77.8% |
Q2 2015 | $3,351,000 | +2538.6% | 410,719 | +2532.8% | 0.02% | +1700.0% |
Q1 2015 | $127,000 | – | 15,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
Beck Bode, LLC | 41,218 | $33,799 | 0.01% |